Search tips
Search criteria 


Logo of annrheumdAnnals of the Rheumatic DiseasesVisit this articleSubmit a manuscriptReceive email alertsContact usBMJ
Ann Rheum Dis. 1989 April; 48(4): 326–330.
PMCID: PMC1003750

Multicentric Castleman's disease associated with rheumatoid arthritis: a possible role of hepatitis B antigen.


A patient with seropositive rheumatoid arthritis and a carrier of hepatitis B surface antigen developed angiofollicular hyperplasia (multicentric Castleman's disease). The hepatitis B virus and the rheumatoid factor may have had a role in the aetiology of this lymphatic disorder. The development of Castleman's disease in association with these factors may provide another clue supporting the reactive nature of this disease.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.3M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Images in this article

Click on the image to see a larger version.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Frizzera G. Castleman's disease: more questions than answers. Hum Pathol. 1985 Mar;16(3):202–205. [PubMed]
  • Gaba AR, Stein RS, Sweet DL, Variakojis D. Multicentric giant lymph node hyperplasia. Am J Clin Pathol. 1978 Jan;69(1):86–90. [PubMed]
  • Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 32-1984. An elderly man with progressive neuropathy and elevated gamma globulin. N Engl J Med. 1984 Aug 9;311(6):388–398. [PubMed]
  • Meyers OL, Klemp P. Lymph node enlargement in rheumatoid arthritis. A case of angio-immunoblastic lymphadenopathy. S Afr Med J. 1982 Dec 25;62(27):1038–1039. [PubMed]
  • Frizzera G, Banks PM, Massarelli G, Rosai J. A systemic lymphoproliferative disorder with morphologic features of Castleman's disease. Pathological findings in 15 patients. Am J Surg Pathol. 1983 Apr;7(3):211–231. [PubMed]
  • Gazitt Y, Margel S, Lerner A, Wands JR, Shouval D. Development of a novel C1q immunoadsorbent for removal of circulating immunecomplexes: quantitative isolation of hepatitis B virus surface antigen and immunecomplexes. Immunol Lett. 1985;11(1):1–8. [PubMed]
  • LOWRY OH, ROSEBROUGH NJ, FARR AL, RANDALL RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed]
  • Keller AR, Hochholzer L, Castleman B. Hyaline-vascular and plasma-cell types of giant lymph node hyperplasia of the mediastinum and other locations. Cancer. 1972 Mar;29(3):670–683. [PubMed]
  • Frizzera G, Peterson BA, Bayrd ED, Goldman A. A systemic lymphoproliferative disorder with morphologic features of Castleman's disease: clinical findings and clinicopathologic correlations in 15 patients. J Clin Oncol. 1985 Sep;3(9):1202–1216. [PubMed]
  • Weisenburger DD, Nathwani BN, Winberg CD, Rappaport H. Multicentric angiofollicular lymph node hyperplasia: a clinicopathologic study of 16 cases. Hum Pathol. 1985 Feb;16(2):162–172. [PubMed]
  • Schroer KR, Franssila KO. Atypical hyperplasia of lymph nodes: a follow-up study. Cancer. 1979 Sep;44(3):1155–1163. [PubMed]
  • Chen KT. Multicentric Castleman's disease and Kaposi's sarcoma. Am J Surg Pathol. 1984 Apr;8(4):287–293. [PubMed]
  • Sagnelli E, Manzillo G, Maio G, Pasquale G, Felaco FM, Filippini P, Izzo CM, Piccinino F. Serum levels of hepatitis B surface and core antigens during immunosuppressive treatment of HBsAg-positive chronic active hepatitis. Lancet. 1980 Aug 23;2(8191):395–397. [PubMed]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group